Le Centre de vaccination AES is now part of the PRELEV Group.

Blog

Our latest blogs

ABRYSVO Vaccine Blog
Vaccination

ABRYSVOᴹᴰ now approved for adults aged 18–59

Health Canada now approves the ABRYSVOᴹᴰ vaccine for adults aged 18 to 59 at high risk of RSV-related complications. This advancement addresses a significant need by finally offering a reliable protection option. The AES Vaccination Center is ready to support each patient with this new recommendation.

Read the blog »
Article – Travel vaccination
Vaccination

Travel Vaccinations: What You Need to Know Before You Go

Travelling is about discovering new horizons, experiencing different cultures, and creating unforgettable memories. But before you pack your bags, there’s one essential step that is often overlooked: vaccination. Depending on your destination, some diseases can pose real risks — and being vaccinated can make all the difference between the trip

Read the blog »